Showing results (391-400 of 435) with videos related to
Sort By:
Pageof 44
Journal of Medicinal Chemistry|December 23, 2015
1,4-Dihydropyridines Active on the SIRT1/AMPK Pathway Ameliorate Skin Repair and Mitochondrial Function and Exhibit Inhibition of Proliferation in Cancer CellsSergio Valente, Paolo Mellini, Francesco Spallotta, et al.Molecular Metabolism|August 9, 2022
Histone lysine demethylase inhibition reprograms prostate cancer metabolism and mechanicsUgo Chianese, Chiara Papulino, Eugenia Passaro, et al.Cancer Research|February 26, 2014
Context-selective death of acute myeloid leukemia cells triggered by the novel hybrid retinoid-HDAC inhibitor MC2392Floriana De Bellis, Vincenzo Carafa, Mariarosaria Conte, et al.Clinical Epigenetics|May 8, 2019
Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cellsClemens Zwergel, Michael Schnekenburger, Federica Sarno, et al.Nature Chemical Biology|October 26, 2023
Targeting ROS production through inhibition of NADPH oxidasesJoana Reis, Christoph Gorgulla, Marta Massari, et al.Cell Death & Disease|October 6, 2025
Adipose-tumor crosstalk in colorectal cancer: Identifying (Epi)genetic biomarkers for tumor progression and cachexiaAda Pesapane, Lucia Capasso, Maria Rosaria Del Sorbo, et al.Journal of Hematology & Oncology|February 22, 2026
UVI5008: the first reversible, non-covalent Bruton's tyrosine kinase epi-inhibitor for B-cell malignanciesCarmela Dell'Aversana, G Sgueglia, C Massaro, et al.European Journal of Medicinal Chemistry|September 30, 2024
Comprehensive structural investigation of a potent and selective CXCR4 antagonist via crosslink modificationAnna Maria Trotta, Vincenzo Mazzarella, Michele Roggia, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 11, 2023
Antitumor Efficacy of Dual Blockade with Encorafenib + Cetuximab in Combination with Chemotherapy in Human BRAFV600E-Mutant Colorectal CancerStefania Napolitano, Melanie Woods, Hey Min Lee, et al.Oncogene|December 9, 2008
Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effectE Lara, A Mai, V Calvanese, et al.Pageof 44